Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03202251 · ClinicalTrials.gov registry record
Deep Brain Stimulation in Patients With LUTS
A clinical trial, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- 6
- Enrollment target
NCT03202251: Completed study, sponsored by The Methodist Hospital Research Institute.
NCT03202251 is a clinical trial that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03202251 has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Deep brain stimulation (DBS) is a neurosurgical procedure using a device that improves motor symptoms of specific neurological and movement disorders such as Parkinson's disease or Essential Tremor. As part of the patient's care, the DBS is implanted when symptoms cannot be satisfactorily controlled with medications or conventional therapies. Lower urinary tract symptoms are common in patients who have underlying neurological or movement disorders and control over lower urinary tract function is poorly understood. In this study investigators are evaluating the effects of DBS on lower urinary tract function.
Primary Outcome
Subjective assessment of Deep Brain Stimulation (DBS) effect on urinary symptoms measured by AUASS questionnaire (from none= 0 to most severe=35)
Interventions
- OTHER It's is a cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2020-03-25 |
What the finished NCT03202251 record still lists
NCT03202251 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which It's is a cohort is the first listed.
NCT03202251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03202251 about?
NCT03202251 is a clinical study titled "Deep Brain Stimulation in Patients With LUTS". Deep brain stimulation (DBS) is a neurosurgical procedure using a device that improves motor symptoms of specific neurological and movement disorders such as Parkinson's disease or Essential Tremor. As part of the patient's care, the DBS is implanted when symptoms cannot be satisfactorily controlled...
What is the current status of trial NCT03202251?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2017-04-11. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT03202251?
The interventions under investigation include: It's is a cohort (OTHER).
Who is sponsoring clinical trial NCT03202251?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI